Yee Laura M, Gary Chan Kwun Chuen
Department of Biostatistics, University of Washington, Seattle, WA, 98195, U.S.A.
Stat Med. 2015 Dec 30;34(30):4057-69. doi: 10.1002/sim.6594. Epub 2015 Jul 27.
As the costs of medical care increase, more studies are evaluating cost in addition to effectiveness of treatments. Cost-effectiveness analyses in randomized clinical trials have typically been conducted only at the end of follow-up. However, cost-effectiveness may change over time. We therefore propose a nonparametric estimator to assess the incremental cost-effectiveness ratio over time. We also derive the asymptotic variance of our estimator and present formulation of Fieller-based simultaneous confidence bands. Simulation studies demonstrate the performance of our point estimators, variance estimators, and confidence bands. We also illustrate our methods using data from a randomized clinical trial, the second Multicenter Automatic Defibrillator Implantation Trial. This trial studied the effects of implantable cardioverter-defibrillators on patients at high risk for cardiac arrhythmia. Results show that our estimator performs well in large samples, indicating promising future directions in the field of cost-effectiveness. Copyright © 2015 John Wiley & Sons, Ltd.
随着医疗成本的增加,越来越多的研究除了评估治疗效果外,还在评估成本。随机临床试验中的成本效益分析通常仅在随访结束时进行。然而,成本效益可能会随时间变化。因此,我们提出一种非参数估计方法来评估随时间变化的增量成本效益比。我们还推导了估计量的渐近方差,并给出了基于Fieller方法的同时置信带的公式。模拟研究展示了我们的点估计量、方差估计量和置信带的性能。我们还使用来自一项随机临床试验——第二次多中心自动除颤器植入试验的数据来说明我们的方法。该试验研究了植入式心脏复律除颤器对心律失常高危患者的影响。结果表明,我们的估计方法在大样本中表现良好,这表明成本效益领域有着广阔的未来发展方向。版权所有© 2015约翰·威利父子有限公司。